Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a site-wide government funding/status notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:32:27.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    New elements show Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and a revision note (v3.4.0). Removed: Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and the older revision (v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T04:39:14.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study record page now labels Results First Posted (Estimated) and Last Update Posted (Estimated), replacing the previous non-estimated labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T03:29:38.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Study status updated to Completed and results posted (Results First Posted 2026-01-13). Related study documents, including the Informed Consent Form and Study Protocol/Statistical Analysis Plan, have been added.
    Difference
    3%
    Check dated 2026-01-14T01:29:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new Locations section was added with Texas as a location; the separate Texas Locations subsection was removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:38:54.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1; this is a minor UI/system update that does not change the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:10:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.